Fortress Biotech (FBIO) Change in Accured Expenses (2010 - 2025)

Fortress Biotech's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$6.5 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 987.64% year-over-year to -$6.5 million; the TTM figure through Dec 2025 stood at -$8.0 million (down 24.74% YoY), while the FY2025 annual figure was -$8.0 million, down 24.74% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at -$6.5 million, down from $6.3 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $43.2 million in Q4 2021, with the low at -$16.9 million in Q3 2023.
• The 5-year median for Change in Accured Expenses is $83000.0 (2022), against an average of $1.4 million.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses sank 8045.54% in 2023, then surged 5776.6% in 2024.
• Fortress Biotech's Change in Accured Expenses stood at $43.2 million in 2021, then tumbled by 110.64% to -$4.6 million in 2022, then surged by 453.18% to $16.2 million in 2023, then tumbled by 95.52% to $728000.0 in 2024, then tumbled by 987.64% to -$6.5 million in 2025.
• Business Quant data shows FBIO's Change in Accured Expenses at -$6.5 million in Q4 2025, $6.3 million in Q3 2025, and -$8.4 million in Q2 2025.